Tyrosine phosphorylation regulates the dimerization of STATs as an essential prerequisite for the establishment of a classical JAK-STAT signaling path. However, most vertebrate STATs contain a second phosphorylation site within their C-termini. The phosphorylated residue in this case is a serine contained within a P(M)SP motif, and in the majority of situations its mutation to alanine alters transcription factor activity. This review addresses recent advances in understanding the regulation of STAT serine phosphorylation, as well as the kinases and other signal transducers implied in this process. The biochemical and biological consequences of STAT serine phosphorylation are discussed.
Introduction
Cytokine receptor signal transduction utilizes STATs both as messengers to the cell nucleus and as activators of many genes whose products orchestrate the physiological changes within a cytokine-treated cell. While STATs share the dual function as signal transducers and activators of transcription with other intracellular mediators of cytokine responses like SMADs, NFkB or Notch, the mechanism converting STATs from latent cytoplasmatic proteins into their active forms is unique. This uniqueness derives from two structural components not found in other families of transcription factors: an SH2 domain and a Cterminal tyrosine residue which becomes phosphorylated in cytokine-stimulated cells, most often by receptor-associated Janus kinases (JAKs). Tyrosine phosphorylation and subsequent SH2 domainmediated homo-or heterodimerization of STATs provide the essential prerequisite for biological activity because dimerization shifts the subcellular localization to the nucleus and it allows STATs to bind DNA.
It appeared initially that a single STAT tyrosine residue is all that becomes phosphorylated as a consequence of cytokine stimulation. For STATs 2 and 6 this may still be true. However, all other STATs were found phosphorylated also on serine residues in a stimulus-regulated manner. With a second phosphorylation event providing the possibility to modulate STAT activity, the question arose which aspect of STAT function (if any) was being regulated and with what consequences for cytokine responses. Moreover, STAT serine kinases were being sought. For individual STATs these issues are far from being resolved, but advances towards understanding the cause for and eect of STAT serine phosphorylation have been made and will be summarized and discussed below.
Known STAT serine phosphorylation sites are located within the C-terminus Evidence for serine phosphorylation of STATs 1 and 3 had initially been obtained by isolating the proteins from 32 P-labeled cells after appropriate stimulation with cytokines and subjecting them to phospho-amino acid analysis (Eilers et al., 1995; Wen et al., 1995; Zhang et al., 1995) . Moreover, cytokine treatment in the presence of the serine kinase inhibitor H7 partially reversed an SDS ± PAGE mobility shift of STATs 3, 4 and 5b isolated from cells after stimulation with IL-6, IL-12 and IL-2, respectively (Beading et al., 1996; Boulton et al., 1995; Cho et al., 1996; Lutticken et al., 1995) .
Sequence alignments of dierent vertebrate STATs reveal blocks of conserved amino acids in virtually every domain except the last approx. 50 ± 150 amino acids, i.e., the portion beyond the phosphorylated tyrosine residue, where conserved amino acids are very infrequent . The Cterminal domains are tightly linked to the transactivation function of STATs because their removal generates transcriptionally inactive proteins, frequently dominant-negative alleles when overexpressed (Caldenhoven et al., 1996; Mui et al., 1996; Shuai et al., 1993) . Comparing the C-termini of STATs 1, 3 and 4 it was noted that unlike the majority of amino acids, a PMSP motif between positions 720 and 730 is perfectly conserved (Wen et al., 1995, Figure 1a) . In addition, STAT5a and STAB5b contain a conserved PSP motif in an equivalent position (Yamashita et al., 1998; Figure 1a ; for reasons of simplicity we will collectively refer to these STATs as P(M)SP-STATs). Since PMSP and PSP sequences are potential serine phosphorylation sites for proline-directed kinases, particularly the MAP family kinases (Clark-Lewis et al., 1991; Gonzalez et al., 1991) , their recognition sparked an immediate interest in the question whether a second STAT phosphorylation site had been uncovered. Conclusive evidence for this was ®rst provided for STAT1 and STAT3. Using phospho-peptide mapping and phospho-amino acid analysis, a cytokine-regulated increase of phospho-serine could be demonstrated, assigned to a C-terminal tryptic peptide, and shown to be abrogated by mutation of S727 . Subsequently the phosphorylation of the P(M)SP motifs of STATs 1, 3, 4, 5a and 5b was established or con®rmed using phosphospeci®c antibodies (Frank et al., 1997; Ng and Cantrell, 1997; Kovarik et al., 1998; Visconti et al., submitted; Yamashita et al., 1998) . Immunoreactivity with such antibodies strongly increased after treatment with appropriate cytokines and where tested it was absent when assaying the respective S-A mutations (Kovarik et al., 1998; Yamashita et al., 1998; Visconti et al., submitted) . In case of STATs 3 and 4, the H7-sensitive SDS ± PAGE mobility shift decreased upon mutation of, respectively, S727 and S721 to alanine (Chung et al., 1997; Visconti et al., submitted) .
The occurrence of serine phosphorylation sites distinct from the C-terminal P(M)SP is suggested by the fact that some (or perhaps all) STATs still contain phospho-serine when mutated to P(M)AP (Chung et al., 1997; Yamashita et al., 1998) . Since nothing is known about such sites except that they may exist, this review will entirely be concerned with serine phosphorylation of the C-terminal P(M)SP.
Evolutionary conservation of the C-terminal serine phosphorylation site
During the evolution of organisms, STATs appear at the metazoan boundary . The most primitive multicellular organism containing STATs with a characteristic SH2 domain and phosphotyrosine residue is Dictyostelium discoideum (Kawata et al., 1997 ). An evolutionary relationship has been proposed, according to which the STAT genes in Dictyostelium and Coenorhabditis elegans represent ancestral forms. However, an early duplication of the ancestral gene must have occurred, eventually giving rise to A-and Btype STATs (Barillas-Mury et al., 1999; Copeland et al., 1995) . Insect STATs from Drosophila melanogaster and Anopheles gambiae, D-STAT and Ag-STAT, respectively, belong with A-type STATs that include also vertebrate STATs 5a, 5b and 6. Vertebrate STATs 1, 2, 3 and 4 are B-type STATs. It is currently not known whether a B-type STAT gene is encoded by, or was lost in, insect genomes. Therefore, ®nal proof is lacking for the assumption that the ancestral STAT gene duplication occurred before the separate evolution of vertebrates and insects (Barillas-Mury et al., 1999) .
All vertebrate homologues of STAT1, STAT3 and STAT4 sequenced to this date include a C-terminal PMSP serine phosphorylation motif and all STAT5s contain the PSP sequence. Thus, the PMSP sequence is characteristic for all B-type STATs except STAT2 and is found in species as distantly related to humans as zebra®sh or Xenopus laevis (Figure 1b,c) . Comparing the zebra®sh and human STAT1 underscores the relevance of PMSP conservation, because only 19 out of 49 amino acid positions in the C-terminus beyond Y701 (human STAT1) are identical and another three positions contain conservative changes. The sequence analyses therefore suggest that the PMSP motif was acquired shortly after the original STAT gene duplication and the emergence of B-type STATs. Since STAT2 is of the B-type, but does not contain a PMSP motif, we speculate that the absence of the phosphorylation site is due to a secondary loss. This assumption is not far-fetched in light of the fact that the C-terminus in STAT2 from dierent species is very divergent (Park et al., 1999; Paulson et al., 1999) and that STAT2 may also have lost or changed its DNA-binding domain. It may represent a special case among STATs.
The situation is much less clear in case of A-type STATs. There is no potential site for a proline-directed kinase (i.e. a SP sequence) in the C-terminus of D-STAT (Hou et al., 1996; Yan et al., 1996) . The Ag-STAT contains a QS 681 PS sequence (Barillas-Mury et ., 1999) . Vertebrate STAT6 contain SS 756 PD (human) or SS 747 PE (mouse) sequences in a position similar to the B-STAT PMSP. As in the case of Ag-STAT there is no available information whether the serines within them are phosphorylated. Vertebrate STAT5 is so far the only example of an A-type STAT where phosphorylation of the C-terminus on serine has been documented.
The available information suggests that duplication of STAT genes and functional diversi®cation occurred in primitive vertebrates or their evolutionary ancestors. The separate evolution of A-and B-type STATs as well as the acquisition of a C-terminal serine phosphorylation motif are dierent facets of the diversi®cation process, which caused STATs to play diverse functions in multiple aspects of cell biology and immunity.
Biochemical and biological implications of STAT serine phosphorylation
Information concerning the consequences of serine phosphorylation of the P(M)SP-STATs is either derived from the analysis of S-A mutants or from the correlation of a phosphorylation event with a particular downstream eect. There are as yet no mice with S-A mutations in the endogenous STAT loci, but the generation of such animals is currently under way.
Activation of transcription
The ®rst analysis of STAT1 and STAT3 S-A mutations showed a reduction of cytokine-stimulated transcription factor activity. With an approx. 80% reduction of interferongamma (IFN-g)-induced transcription factor activity the eect of the mutation was very pronounced for the STAT1 dimer. It was observed either in transient transfection assays or after complementation of STAT1-de®cient U3A cells with STAT1 S727A and assaying the endogenous interferon regulatory factor-1 (IRF-1) target gene . The link between phosphorylation of STAT1 on S727 and increased transcription was strengthened by studies showing that stimuli causing serine phosphorylation increase the expression of a Stat1 target gene upon further treatment with IFN-g (Goh et al., 1999; Kovarik et al., 1998 Kovarik et al., , 1999 Stoiber et al., 1999) . STAT1 S727 phosphorylation is not required for transcriptional activity of the ISGF3. This complex of STAT1-STAT2-IRF-9 proteins is assembled in IFN-a-treated cells. ISGF3 functions in U3A cells after complementation with either STAT1b that lacks the entire C-terminus or with a S727A mutant (Bromberg et al., 1996; Muller et al., 1993) . In spite of this, a fraction of ISGF-3 complexes was recently shown to contain S727-phosphorylated STAT1 (Goh et al., 1999) . The signi®cance of this ®nding is unclear.
STAT3 S727A-mediated activation of a transfected IRF-1 promoter in response to IFN-a was reduced by about 50% . The S-A mutation caused a similar eect on the IRF-1 promoter in IL-6-treated hepatoma cells (Schuringa et al., 1999) , but in a comparable situation wtSTAT3 and the S727A mutant were reported to have similar activity in mobilizing the haptoglobin acute phase promoter (Kim and Baumann, 1997). Therefore, the requirement for a phosphorylated S727 may vary with the promoter and/or cellular context. Support for this assumption stems from data showing that the entire STAT3 Cterminus appears to be dispensable for activating the a2-macroglobulin acute phase promoter in hepatoma cells, but not in immortalized simian kidney ®broblasts (COS cells; Sasse et al., 1997) .
Signal transduction pathways causing phosphorylation of STAT3 S727 can decrease STAT3-dependent transcriptional responses (Jain et al., 1998 (Jain et al., , 1999 Lim and Cao, 1999; Sengupta et al., 1998) . The interpretation of these data in molecular terms is rendered dicult by the fact that such pathways also aect STAT3 tyrosine phosphorylation. As will be discussed below, S727-independent and S727-dependent routes of down-modulating STAT3 tyrosine phosphorylation have been described.
As in the case of STATs 1 and 3, mutation of S721 to alanine decreased the transcription factor activity of STAT4 when assayed in transfected, IL-12-stimulated cells (Visconti et al., submitted) . By contrast, mutation of S725 or S730 in STAT5a and STAT5b, respectively, did not aect transcriptional activation of a prolactinresponsive promoter in COS cells (Yamashita et al., 1998) . There are several potential explanations for this. Most simply, phosphorylation of these STAT5 residues may not aect transcription. Alternatively, the requirement for a phosphorylated serine could be promoter or cell type-dependent, as may also be the case for STAT3.
DNA binding Some reports indicate a correlation of STAT1 or STAT3 serine phosphorylation with increased DNA-binding (Eilers et al., 1995; Ng and Cantrell, 1997; Zhang et al., 1995) . Mutation of either STAT1 or STAT3 did not produce any evidence for an eect of S727 phosphorylation on DNA-binding. Mutation of S725 and S730 in STAT5a and STAT5b, respectively, was similarly without an eect on the ability of these proteins to bind DNA (Yamashita et al., 1998) . Therefore, if serine phosphorylation indeed aects DNA binding, other serine residues must be involved. Rigorous proof for this assumption has not been provided.
Nuclear translocation There is currently no evidence for an in¯uence of serine phosphorylation on the nuclear translocation of STATs. C-terminal truncations removing the P(M)SP motif have no apparent eect on the subcellular localization of STATs.
Interdependence of serine and tyrosine phosphorylation The enhancement of transcription by serine phosphorylation could potentially be explained by a positive in¯uence of serine phosphorylation on STAT tyrosine phosphorylation, i.e. an increased anity for activated receptors and/or JAKs. However, available information argues against this possibility. Reconstitution of STAT1-de®cient U3A cells with the STAT1 S727A mutant had no eect on IFN-g-mediated tyrosine phosphorylation (Zhu et al., 1997) . Moreover, the serine kinase inhibitor H7 inhibited IFN-gmediated serine phosphorylation without a concomitant eect on tyrosine phosphorylation (Kovarik et al., 1998) .
As in the case of STAT1, tyrosine phosphorylation of STAT3 is not enhanced by a phosphorylated S727. In fact, serine phosphorylation may decrease the rate of tyrosine phosphorylation. Chung et al. (1997) reported an increase in EGF-induced tyrosine phosphorylation of a transfected STAT3 S727A mutant compared to wt STAT3. This suggests that S727 phosphorylation either inhibits tyrosine phosphorylation or that it increases tyrosine dephosphorylation. To reconcile this ®nding with the enhancement of transcription suggested by analysis of the S-A mutant, one has to assume that phospho-S727-dependent events (cofactor association?) overcompensate the negative eect on tyrosine phosphorylation. Moreover, since down-modulation of STAT3 tyrosine phosphorylation through a MEK/ERK pathway can also occur independently of S727 phosphorylation (Sengupta et al., 1998) , the relative contribution of phospho-S727 to the regulation of STAT3 tyrosine phosphorylation in vivo is presently unclear.
The inverse relationship, the impact of tyrosine phosphorylation on serine phosphorylation has also been tested in STAT1-de®cient U3A cells after reconstitution with STAT1 Y701F (Zhu et al., 1997) . The authors concluded that constitutive or IFN-g-mediated serine phosphorylation occur without the need for a phosphorylated tyrosine. That the two phosphorylation events can, in principle, be uncoupled is further supported by studies showing serine phosphorylation by surface stimuli that do not cause concomitant tyrosine phosphorylation of STAT1 or STAT3 (Table 1; Ceresa and Pessin, 1996; Gotoh et al., 1996; Kovarik et al., 1998 Kovarik et al., , 1999 Kuroki and O'Flaherty, 1999; Lim and Cao, 1999; Ng and Cantrell, 1997) . Moreover, STAT1 dimerized via a fused estrogen receptor hormone-binding domain moves to the nucleus and activates transcription, but transcriptional activity is hampered by mutation of S727. This further suggests that a non-tyrosine-phosphorylated STAT becomes phosphorylated on S727 in vivo (Milocco et al., 1999) .
Studying the IFN-g-response in macrophages we noted that about 90% of the serine-phosphorylated STAT1 is found in the population of molecules that is also tyrosine phosphorylated (Kovarik et al., 1998) . This suggests a hitherto unde®ned supportive role of the tyrosine phosphate on serine phosphorylation, or a preferential serine-dephosphorylation of the non-tyrosine-phosphorylated STAT1. In conclusion, there is no mechanistic impediment for serine and tyrosine phosphorylation of STATs to occur independently. However, we have reason to further consider a positive in¯uence of tyrosine phosphorylation on serine phosphorylation in the context of an IFN-g response.
Protein association It is reasonable to assume that the increased transcription factor activity of serine-phosphorylated STATs, particularly STAT1, is due to protein interactions occurring preferentially after the phosphorylation of S727. Transcriptional cofactors or coactivators (corepressors) are attractive candidates for such STAT-interacting proteins (reviewed in Decker and Kovarik, 1999) . To this date there is a single report about a phospho-S727-enhanced protein association. The human MCM5 protein, previously known for its role in DNA replication, was isolated by a biochemical approach using the STAT1 C-terminus as an anity matrix and its association was reduced if the matrix contained either the S727A or an L724A mutation . Transcription factor activity of STAT1 varied during the cell cycle and correlated with the level of nuclear MCM5, which is high in G1 and low during S phase. Thus, MCM5 may couple the transcription factor activity of STAT1 (and other STATs?) to the cell cycle, but its role concerning the enhancement caused by serine phosphorylation in resting cells is unclear. Several other proteins copuri®ed with MCM5 on the STAT5 anity matrix and we may expect that the nature and signi®cance of these other proteins will soon be revealed.
Most, or even all STATs associate with the coactivators p300 and CBP and this interaction results in a moderate increase of transcription factor activity in transient transfection assays (Bhattacharya et al., 1996; Gingras et al., 1999; McDonald and Reich, 1999; Paulson et al., 1999; P®tzner et al., 1998; Zhang et al., 1996) . Association of STAT1 with p300/CBP has been carefully studied and no evidence for an in¯uence of phospho-S727 was found (Zhang et al., 1996) . The impact of P(M)SP phosphorylation on protein interactions with the STAT C-termini is therefore largely unexplained and awaits the further identi®cation of partner molecules.
Biological implications of STAT serine phosphorylation A number of cell surface receptors are capable of stimulating the serine phosphorylation of STATs without activating a STAT tyrosine kinase (Table 1) . On the other hand, we are not aware of a receptor stimulating tyrosine phosphorylation, but not serine phosphorylation of a P(M)SP-STAT. Therefore, a unidirectional exploitation of the possibility to uncouple tyrosine and serine phosphorylation predominates in biological systems. This suggests that serine phosphorylation alone is a means of priming STATs for an altered transcriptional response once a second stimulus causing tyrosine phosphorylation is received. From the current literature we would infer primed STATs to cause increased transcription in most cases, but the negative eect reported for STAT3 complicates the issue and demands further clari®cation.
The signi®cance of STAT1 serine phosphorylation in vivo has been studied in U3A cells complemented with STAT1 S727A. The lack of growth inhibition or the establishment of the antiviral state by IFN-g in these cells implies that STAT1 dimers with the S727A mutation are biologically inactive (Bromberg et al., 1996; Horvath and Darnell, 1996) . The critical importance of S727 phosphorylation for the biological impact of IFN-g is further supported by studies with mediators of in¯ammation (LPS, TNF-a), which cooperate with IFN-g in the activation of macrophages. These prime STAT1 for enhanced transcription factor activity through phosphorylation of S727 (Kovarik et al., 1998 .
IFN-a/b displays normal biological activity in U3A cells expressing STAT1 S727A, suggesting that type I IFN employs predominantly the ISGF3 complex (STAT1-STAT2-IRF-9) for the expression of critical target genes rather than the STAT1 dimer (Bromberg , 1996) . As mentioned in a preceding section, the ISGF3 complex does not require the STAT1 Cterminus and appears to employ the STAT2 transactivating domain for transcriptional activity. STAT3-de®cient cells are only beginning to become available and there are no published studies with STAT3 S727A-reconstituted cells so far. Therefore, it is not yet possible to judge the importance of serine phosphorylation for STAT3-dependent responses, e.g. to EGF/ PDGF, IL-6 family cytokines or to IL-10. In spite of this, recent data support the notion that STAT3 serine phosphorylation is important for biological responses. STAT3 is constitutively phosphorylated in v-Src-transformed cells and participates in v-Src-mediated ®bro-blast transformation (Bromberg et al., 1998; Turkson et al., 1998 Turkson et al., , 1999 . Constitutively active STAT3 was shown to display oncogenic potential (Bromberg et al., 1999) . Overexpressed STAT3 S727A exerted a dominantnegative eect on v-Src-mediated transformation (Bromberg et al., 1998) . Furthermore, inhibition of STAT3 serine phosphorylation resulted in reduced transformation by the v-src, but not the v-ras oncogene (Turkson et al., 1999) . Constitutive STAT3 serine phosphorylation was also reported for B-cell-derived tumors (Frank et al., 1997) . Taken together, these ®ndings suggest an important role for STAT3 and the phosphorylation of S727 in cellular growth control.
Unlike STAT1 and STAT3, there are currently no available data to estimate the importance of STAT4 or STAT5 serine phosphorylation for their biological activity. Uncovering the relevance of serine phosphorylation for cellular responses or the integrity of organisms is a major challenge for future research.
Kinases and other signal transducers that participate in the serine phosphorylation of STATs
Indications as to which signaling pathways target the STAT P(M)SP motif were ®rst (and mostly) obtained using more or less speci®c inhibitors of serine kinases. These include the PD98059 inhibitor of MEK1/2 (also called MKK1/2), upstream kinases of the extracellular signal-regulated kinases (ERK1/2), the p38MAPK inhibitor SB203580, the PI3 kinase inhibitor Wortmannin, and H7, a compound with a broader spectrum of inhibitable serine kinases. As will be described below, pharmacological studies were in some cases complemented by experiments with dominant-negative, constitutively active, or inhibitor-resistant kinase alleles, as well as with in-vitro phosphorylation assays (Table 2) . Before proceeding to a more detailed description of individual signaling routes we would like to point out the following more general aspects of the relationship between signal transducers and STAT serine phosphorylation: (1) Serine phosphorylation of one STAT can occur through dierent signal transduction paths. For example, STAT1 S727 phosphorylation in macrophages is sensitive to SB203580 in stress of LPS responses, but insensitive to this inhibitor in the IFN-g response . Similarly, STAT3 S727 phosphorylation in response to EGF, PDGF, insulin, IL-2, BCR or TCR stimulation is sensitive to PD98059 and, where tested, insensitive to H7, whereas the opposite is true for IL-6 or IFN-a (Chung et al., 1997; Ng and Cantrell, 1997; Stephens et al., 1998; Su et al., 1999) . (2) S727 phosphorylation of dierent STATs by signals from the same cell surface receptor can be routed through distinct signaling paths. This has been documented for bacterial LPS or for UVirradiation which causes SB203580-sensitive S727 phosphorylation in case of STAT1, but SB203580-insensitive S727 phosphorylation in case of STAT3 Lim and Cao, 1999) . (3) Mitogen-activated protein kinase (MAPK) pathways {ERK, c-Jun kinases (JNK) or p38MAPK} play an important role in the phosphorylation of the PMSP motif. By using pathway-speci®c inhibitors and/or by forced activation of MAPK pathways in transient transfection, STATs 1, 3, 4 and 5 proved to be targets of either growth factor regulated MAPK (ERK1/2) or stress-regulated MAPK (p38, JNKs), or both (references provided below). (4) The P(M)SP motif may also be phosphorylated through pathways not involving MAPK. This probably applies for those phosphorylation events, which are sensitive to H7, but insensitive to PD98059 and SB203580. One such example is STAT3 S727 phosphorylation in response to IL-6 (Chung et al., 1997; Schuringa et al., 1999) . (5) In-vitro kinase activity is dicult to evaluate with regard to P(M)SP kinase activity in-vivo. Particularly in case of ERKs, JNKs and p38MAPK, in-vitro phosphorylation of the consensus PMSP motif is an expected result, but sheds little light on the nature of the STAT kinase(s) acting in cells, unless complemented by additional data. The enzymatic parameters for the reaction between a candidate kinase and a STAT substrate should be comparable to those obtained with known in-vivo substrates and a tight correlation should exist between activation of a candidate kinase and STAT phosphorylation in vivo. If these criteria are rigorously applied to all cellular responses causing STAT serine phosphorylation, a question mark must often remain behind the proposed STAT P(M)SP kinases. Inconsistent results have been obtained with dierent experimental protocols concerning the phosphorylation of STATs by dierent MAPK in-vitro or with regard to the eects of particular signaling pathways on serine phosphorylation of, and transcriptional activation by STATS [e.g. Lim and Cao (1999) and Schuringa et al. (1999 ), or Chung et al. (1997 and Turkson et al. (1999) , or Schuringa et al. (1999) and Turkson et al. (1999) ].
The ERK pathway Compelling evidence that ERKs, particularly ERK2, are STAT kinases or upstream of a STAT P(M)SP kinase has been provided for STAT3. Inhibition of phosphorylation by PD98059 is thought to be a quite speci®c criterion for an involvement of the ERK pathway and this compound interferes with STAT3 serine phosphorylation by receptor tyrosine kinases, IL-2, and lymphocyte antigen receptors (Chung et al., 1997; Ng and Cantrell, 1997; Su et al., 1999) . The general picture emerges that STAT3 is usually phosphorylated on S727 whenever ERK2 is active in a cell. ERKs phosphorylate STAT3 S727 in vitro with unknown reaction kinetics (Chung et al., 1997; Turkson et al., 1999) . ERK2 and STAT3 can also be co-immunoprecipitated from cells (Jain et al., 1998) . All facts considered ERK2 is a bona ®de STAT3 serine kinase.
As mentioned before, ERK activity has been linked to the negative regulation of STAT3 activity. We would again like to stress the fact that this is due to S727-STAT serine phosphorylation T Decker and P Kovarik . increased phosphorylation at Ser727 in v-Src transformation dependent transformed cells . correlation of phosphorylation at Ser727 with activation of JNK and p38 in v-Src transformed cells Continued dependent and independent down-regulation of tyrosine phosphorylation and does not indicate a negative eect of phospho-S727 per se on STAT3-mediated transcription. To our knowledge it has not been tested whether the induction of the SOCS proteins, STAT-induced feedback inhibitiors of JAKs (Hilton, 1999) , depends on ERK activity. This might explain MAPK-dependent down-regulation of STAT tyrosine phosphorylation. ERK2 was also connected to serine phosphorylation of STAT1. The enzyme co-immunoprecipitated with STAT1 and a dominant-negative ERK allele decreased transcription in response to IFN-a (David et al., 1995) . In case of IFN-g, a dominant-negative allele of the Pyk2 tyrosine kinase suppressed ERK activation and at the same time the S727 phosphorylation of STAT1 (Takaoka et al., 1999) . While these data support a role for ERKs as STAT1 serine kinases, several lines of evidence argue against a general validity of the concept. First, particularly IFN-g is a poor activator of ERKs compared to e.g. ligands of tyrosine kinase receptors in most cell types and the activation of ERKs in dierent situations does not correspond to the level of STAT1 serine phosphorylation (Kovarik et al., 1998) . Second, the MEK inhibitor PD98059 was reported to have no or only a partial eect on IFN-induced STAT1 S727 phosphorylation (Goh et al., 1999; Ala-Aho et al., 2000) . Third, up-or downregulation of ERK activity had no eect on STAT1 serine phosphorylation in the IFN-g response (Zhu et al., 1997) . Fourth, STAT1 is a very poor in-vitro substrate for ERKs (Chung et al., 1997) ; Kovarik P and Decker T (2000) , unpublished results). These ®ndings present considerable evidence against ERKs being STAT1 S727 kinases.
STAT5, particularly the STAT5a isoform, was found to be constitutively phosphorylated on serine in Cos cells, Nb2 lymphocytes and HC11 mammary gland epithelial cells (Kirken et al., 1997a,b; Wartmann et al., 1996) . Constitutive phosphorylation of STAT5a S725, or STAT5b S730 was reduced by treating cells with PD98059 (Yamashita et al., 1998) . In marked contrast, the enhanced serine phosphorylation of STAT5a and STAT5b observed after stimulation with prolactin or IL-2 was insensitive to the inhibition with either PD98059 or Wortmannin, suggesting that MEK-dependent as well as PI3 kinase and MEK-independent pathways control, respectively, constitutive and induced S725 and S730 phosphorylation of the STAT5 isoforms (Beadling et al., 1996; Kirken et al., 1997a; Yamashita et al., 1998; reviewed in Grimley et al., 1999) .
The JNK pathway The only STAT linked to the JNK pathway until now is STAT3. Similar to STAT1, STAT3 S727 phosphorylation is caused by stressing cells with UV irradiation or hyperosmolarity, or by exposing them to in¯ammatory signals like TNF-a and LPS. Unlike STAT1, however (see below), the UVactivated signaling path for STAT3 phosphorylation is resistant to SB203580 (Lim and Cao, 1999) . Transfection of cells with the JNK kinase kinase MEKK1 caused S727 phosphorylation of STAT3 and produced in-vitro STAT3 S727 kinase activity in JNK-immunoprecipitates, a ®nding consistent with the in-vitro phosphorylation of STAT3 by puri®ed JNK (Turkson et al., 1999) , but inconsistent with yet another study ®nding very little STAT3 kinase activity in anisomycintreated cell extracts which contain high levels of JNK activity (Schuringa et al., 1999) . Similar to the ERK pathway, activation of a MEKK1-MKK7-JNK signaling path caused inhibition of STAT3 tyrosine phosphorylation and, therefore, an inhibition of gene transcription (Lim and Cao, 1999) . STAT3 S727 phosphorylation in response to IL-6 was inhibited by dominant-negative alleles of the Vav guanine nucleotide exchange factor, the small G-protein Rac-1 and the second putative JNK kinase MKK4 (Schuringa et al., 1999) . Surprisingly however, the authors of this report found very little JNK activation by IL-6 and concluded that despite a requirement for MKK4, JNK was not the relevant STAT3 kinase. It is also puzzling that the study by Schuringa et al. (1999) implies a stimulatory role for MKK4 regarding STAT3-dependent transcriptional responses to IL-6, whereas its presumptive functional analogue MKK7 inhibits STAT3 tyrosine phosphorylation (Lim and Cao, 1999). . resistance to PD98059 independent n.d. (Yamashita et al., 1998) n.d.=not determined JNK activity was also suggested to be required for STAT3-dependent ®broblast transformation. As in the case of IL-6, dominant-negative MKK4 inhibited STAT3 transcriptional activity in cells expressing v-Src. The Ras and Rac-1 GTPases as well as a member of the mixed-lineage kinase family were placed upstream of MKK4-JNK in this situation (Turkson et al., 1999) .
The p38MAPK pathway STAT serine phosphorylation caused by a variety of stimuli is sensitive to the inhibition of p38MAPK. An involvement of the kinase is further suggested by transfection experiments employing dominant-negative or constitutively active p38MAPK kinase (MKK6, Goh et al., 1999; Visconti et al., submitted) , or an inhibitor-resistant p38MAPK . p38MAPK phosphorylates S727 of Stat1 and Stat3 in vitro Turkson et al., 1999) , but, is unclear whether this applies to cells as well.
STAT1 S727 phosphorylation in response to cellular stress (UV irradiation) or in¯ammatory signals (LPS, TNF-a) is inhibited by SB203580 . Cells expressing an SB203580-resistant p38MAPK display SB203580-resistant UV-induced S727 phosphorylation, which clearly positions p38MAPK upstream of STAT1 in situations of stress or in¯ammation. The kinase speci®cally phosphorylates STAT1 S727 in vitro, however, with a signi®cantly lower rate of turn-over compared to the known in-vivo substrate MAPKAP-K2. Activation of p38MAPK by signals of stress or in¯ammation correlates well with STAT1 S727 phosphorylation, but the kinase is activated about 5 ± 10 min earlier than the STAT. This may indicate intermediate steps or a need for relocation of p38MAPK from the nucleus to the cytoplasm. In pursuit of the former hypothesis, cells de®cient for the p38MAPK substrate kinase MAPKAP-K2 were tested for STAT1 S727 phosphorylation in response to UV and no signi®cant dierence to wt cells was found .
While SB203580 also clearly inhibits the synergistic S727 phosphorylation of STAT1 by IL-12 and IL-2 and there is a good correlation to p38MAPK activation in this situation (Gollob et al., 1999) , there is a controversy with regard to a role for p38MAPK in IFN-g-mediated STAT1 S727 phosphorylation. Studying macrophages we did not detect an eect of SB203580 on S727 phosphorylation in response to IFN-g and p38MAPK activation by the cytokine in macrophages and some other cell types was insignificant . By contrast, Goh et al. (1999) placed p38MAPK upstream of STAT1 in IFNg-signaling, based on a twofold activation by IFN-g in HeLa cells and a rather small inhibitory eect of SB203580 on STAT1 phosphorylation. While we hypothesize the existence of a p38MAPK-independent STAT1 kinase in the IFN-g response based on our macrophage results, we do not rule out the existence of alternative pathways in other cell types.
Two groups independently reported the activation of the p38MAPK pathway by type I IFN (IFN-a/b; Goh et al., 1999; Uddin et al., 1999) . In the presence of SB203580 STAT1 serine phosphorylation in response to IFN-a was inhibited and a reduced IFN-astimulated transcriptional activity of an ISGF3 (STAT1-STAT2-IRF-9 complex)-dependent reporter gene was noted (Goh et al., 1999; Uddin et al., 1999) . For reasons explained above, serine phosphorylation of STAT1 is unlikely to aect the transcriptional activity of ISGF3. Goh et al. (1999) found a requirement for p38MAPK also in ISGF3 assembly, but Uddin et al. (1999) did not con®rm this result. Therefore, the precise role of p38MAPK in transcriptional responses to IFN-a remains an open question.
As in the case of JNKs, the p38MAPK pathway was suggested to be important for STAT3 activity in the context of v-Src-mediated cell transformation. v-Srcinduced phosphorylation of STAT3 S727, the transcriptional activity of STAT3, and cell transformation were inhibited by SB202190, another speci®c p38MAPK inhibitor (Turkson et al., 1999) . Like the MKK4-JNK module, the MKK6-p38MAPK module was suggested to localize in a signaling path downstream of the Ras and Rac-1 GTPases, and of (a) member(s) of the mixedlineage family of MAPK kinase kinases.
STAT4 is phosphorylated on S721 in cells transfected with a constitutively active MKK6, suggesting it too can be a target of the p38MAPK pathway (Visconti et al., 1999, submitted) . IL-12 activates p38MAPK, at a rather low level (Gollob et al., 1999; Visconti et al., 1999, submitted) This may suce to mediate the phosphorylation of Stat4 S721 seen after IL-12 treatment, but alternative signaling routes cannot be ruled out.
Finally, it should be noted that the p38MAPK pathway might also have an impact on STAT tyrosine phosphorylation. Hyperosmolarity treatment of certain cell types leads to the phosphorylation of STATs 1 and 3 on tyrosine and this eect can be inhibited by SB203580 or by dominant-negative p38MAPK or MKK6 (Bode et al., 1999) . Activation of JAKs does not appear to be aected and the question arises how a p38MAPK-dependent pathway causing tyrosine phosphorylation of STATs might be shaped.
Protein kinase C delta In search of an H7-sensitive, IL-6 activated STAT3 serine kinase, Jain and coworkers came upon PKCd (Jain et al., 1999) . The enzyme associated with STAT3 in an IL-6-dependent fashion, phosphorylated STAT3 in-vitro, and a dominant-negative form blocked S727 phosphorylation in response to IL-6. Like MAPK pathways, PKCd was reported to have a negative impact on STAT3 DNAbinding (tyrosine phosphorylation?) and on STAT3 transcriptional activity. To link these data with other studies on the same subject, PKCd would have to be connected to the Vav-Rac-MKK4 pathway proposed by Schuringa et al. (1999) . mTOR kinase The IL-6 family cytokine CNTF causes STAT3 activation in neuroblastoma cells. Yokogami et al. (2000) reported that the drug rapamycin inhibits CNTF-induced STAT3 S727 phosphorylation and Stat3-mediated reportergene transcription to the same extent as co-transfection of the STAT3 S-A mutant. The mTor kinase, a phosphatidylinositol kinase-related enzyme, is sensitive to rapamycin treatment. Immunoprecipitated mTOR phosphorylated a STAT3 substrate on S727 in vitro. Based on these results, the authors of this study suggested mTOR to be a CNTF-responsive STAT3 serine kinase.
Protein kinase R (PKR) STAT1-dependent transcription in IFN-g-treated ®broblasts is strongly reduced upon targeted disruption of the pkr gene. Consistent with this result, Ramana et al. (2000) reported PKRde®ciency to cause the virtual absence of S727 phosphorylation in response to IFN-g. The position of PKR in an IFN-g-responsive signaling path targeting STAT1 is unknown. Based on earlier ®ndings, a direct enzymatic activity of PKR on STAT1 appears very unlikely (Wong et al., 1997) .
Dephosphorylation of STAT serine residues
Phosphatase 2A treatment in-vitro was shown to reduce the SDS ± PAGE mobility shift of STAT4 which is at least partially due to the phosphorylation of S727 (Cho et al., 1996) . Moreover, treatment of cells with inhibitors of PP2A causes STAT3 S727 phosphorylation (Woetmann et al., 1999) . If physiologically relevant these results suggest that permanent PP2A activity be required to keep STATs dephosphorylated on S727 and that an increase in phosphorylation demands the inhibition of this phosphatase. However, our knowledge of STAT serine dephosphorylation is at a very preliminary stage.
Concluding remarks
The generation of phosphospeci®c antisera recognizing serine-phosphorylated STATs has greatly facilitated the analysis of conditions under which STAT serine phosphorylation at the C-terminal P(M)SP motif occurs. Therefore, considerable information has been gathered about biological stimuli that cause serine phosphorylation. While it is clear at least in some cases that serine phosphorylation in¯uences the transcriptional activity of STATs, the mechanisms by which this occurs, as well as the biological impact it causes, are unclear in most situations. Signal transduction pathways are beginning to emerge, but much more needs to be learned about the kinases phosphorylating STATs on serine in dierent situations. This review is a snapshot documenting the current situation in a dynamic process aimed at providing more de®nitive answers about causes and eects of STAT serine phosphorylation.
